BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2554504)

  • 1. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
    Faivre R; Neuhart E; Mirshahi M; Mirshahi M; Soria C; Soria J; Bassand JP; Caen JP; Maurat JP
    Semin Thromb Hemost; 1989 Oct; 15(4):435-9. PubMed ID: 2554504
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
    Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
    Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin and pulmonary embolism.
    Nardini S
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):247-9. PubMed ID: 8766203
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and management of deep venous thrombosis].
    Páramo JA; de Gaona ER; García R; Rodríguez P; Lecumberri R
    Rev Med Univ Navarra; 2007; 51(1):13-7. PubMed ID: 17555115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinzaparin as an antithrombotic: an overview.
    Fegan CD
    Hosp Med; 1998 Feb; 59(2):145-8. PubMed ID: 9797891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern strategy for diagnosis and treatment of pulmonary embolism.
    Laaban JP
    Haemostasis; 1999 Dec; 29 Suppl S1():21-2. PubMed ID: 10629400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic strategy in venous thromboembolic disease (VTD)].
    Arch Bronconeumol; 1994 Dec; 30(10):498-505. PubMed ID: 7827764
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications for thrombolytic agents in venous thrombosis and pulmonary embolism].
    Serradimigni A; Romani A; Chiche G; Aubry J; Philip F
    Rev Prat; 1981 Nov; 31(53):3793-4 passim. PubMed ID: 7313474
    [No Abstract]   [Full Text] [Related]  

  • 14. Current developments in thrombolytic therapy.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1973; 56():201-10. PubMed ID: 4617330
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinolytics. 46].
    Wagler M
    Pharm Prax; 1970; 6():141-2. PubMed ID: 4195438
    [No Abstract]   [Full Text] [Related]  

  • 17. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 18. Opinions regarding the diagnosis and management of venous thromboembolic disease. ACCP Consensus Committee on Pulmonary Embolism.
    Chest; 1996 Jan; 109(1):233-7. PubMed ID: 8549189
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic treatment of deep vein thrombosis and lung embolism].
    Scheffler P; von Blohn G; Hellstern P; Köhler M; Wenzel E
    Behring Inst Mitt; 1986 Feb; (79):241-9. PubMed ID: 3718410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
    de los Santos-Sastre S
    An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.